Saturday, 31 May 2014

New Drug Shows Promise for Resistant Thyroid Cancer

Lenvatinib shrunk tumors in 65 percent of those taking the drug, according to late-stage research via Resurrection Health Care - Daily News More READ

No comments:

Post a Comment